Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready • 7 patents granted in the last 365 days
Allen Institute maintains a patent portfolio in the Biotechnology & Pharmaceuticals technology area. There is currently 1 pending office action associated with the company's filings. This 1 action is being processed in 1 distinct art unit, reflecting the specialized nature of biotechnology examination. Prosecution is overseen by 1 distinct examiner.
Alyssa G Weston is the busiest examiner for the portfolio, holding 1 busiest examiner pending action. This 1 action represents the full extent of the current pending matters for the Allen Institute. The concentration in the Biotechnology & Pharmaceuticals area suggests that the pending claims are likely focused on life sciences or medical research.
Practitioners can tailor their approach to the specific requirements of the 1 distinct art unit involved. Because there is only 1 pending office action, the administrative complexity is minimal. The involvement of Alyssa G Weston as the sole examiner allows for a consistent and focused dialogue during the prosecution of this 1 pending office action.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Double-patenting + other | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| WESTON, ALYSSA G | 1 | 59.8% | +50.9% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18698499 | ARTIFICIAL EXPRESSION CONSTRUCTS FOR MODULATING GENE EXPRESSION IN THE CEREBELLUM AND A SECONDARY CELL TYPE | WESTON, ALYSSA G | — |
| Art Unit | Apps |
|---|---|
| 1633 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18698499 | ARTIFICIAL EXPRESSION CONSTRUCTS FOR MODULATING GENE EXPRESSION IN THE CEREBELLUM AND A SECONDARY CELL TYPE | WESTON, ALYSSA G | 1633 | §102§112DP | Non-Final OA | — | Pending | Apr 04, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial